SUZHOU/BEIJING, (Reuters) - Chinese vaccine developer CanSino Biologics is in talks with Russia, Brazil, Chile and Saudi Arabia to launch a Phase III trial of its experimental COVID-19 vaccine, its co-founder said yesterday.
The article China’s CanSino in talks for COVID-19 vaccine Phase III trial in Brazil, Chile appeared first on Stabroek News.